Sullivan Adam Taylor 4
4 · Core Scientific, Inc./tx · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Sullivan Adam Taylor
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2025-12-31+159,308→ 4,523,244 total - Tax Payment
Common Stock
2025-12-31$15.08/sh−117,540$1,772,503→ 4,405,704 total
Footnotes (3)
- [F1]Represents the acquisition of additional performance-based restricted stock units in connection with the 300% vesting of the second installment of the Reporting Person's performance-based restricted stock units granted on June 14, 2024, and previously reported at 100% vesting in the Form 4 filed by the Reporting Person on June 17, 2024.
- [F2]Reported amount reflects the acquisition of 336 shares of Common Stock that the Reporting Person received on December 24, 2025 for no consideration in connection with an in-kind distribution by XMS XPDI Sponsor Holdings LLC, which was exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-9 under the Exchange Act.
- [F3]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.